BCL2 and Burkitt lymphoma: Herein, our study demonstrated that icaritin showed cytotoxicity, inhibited the two critical factors, c-Myc and Bcl-2, in Burkitt lymphoma cells, and provided a rational for the further preclinical and clinical evaluation of icaritin for Burkitt lymphoma therapy.